RevMed

Alere Scarborough, Inc. D1200 Alere NMP22 BladderChek Test

Company Name
Alere Scarborough, Inc.
Catalog Number
D1200

Description

The Alere NMP22 BladderChek Test is an in vitro immunoassay intended for the qualitative detection of the nuclear mitotic apparatus protein (NuMA) in urine of persons with risk factors or symptoms of bladder cancer or with a history of bladder cancer.
Have questions or need more information? Contact Us
RevMed is an independent marketplace for reselling medical devices and equipment. We are not affiliated with or endorsed by manufacturers, and all trademarks and brand names belong to their respective owners. Product images and descriptions are for reference only, and RevMed does not provide medical advice, training, or support.
Find Savings Automatically!
Your trusted browsing companion

Additional Details

Device Identifier
10811877010569
Is RX
No
Is Over the Counter
No
Requires Sterilization
No
Is Sterile
No
Is Single Use
Yes

Barcode Mapping

Unit of MeasurementEachesGTIN
Each110811877010569